Recherche
-
Methodological guidelines to estimate population-based health indicators using linked data and/or machine learning techniques
(Archives of Public Health. vol. 80, n° 1, pp. 9, 2022-01-04)Article de revueLibre accès -
Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data
(Nature Communications. vol. 12, n° 1, pp. 4385, 2021-07-19)Article de revueLibre accès -
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
(Nature Communications. vol. 12, n° 1, pp. 5215, 2021-09-01)Article de revueLibre accès -
New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project
(Journal of Clinical Medicine. vol. 10, n° 16, 2021-08-21)Article de revueLibre accès -
Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study
(Epidemics. vol. 46, pp. 100744, 2024-03-01)Article de revueLibre accès -
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
(eLife. vol. 11, pp. e75427, 2022-07-08)Article de revueLibre accès -
Evaluating the Use of Generalized Dynamic Weighted Ordinary Least Squares for Individualized Hiv Treatment Strategies
(Annals of Applied Statistics. vol. 17, n° 3, pp. 2432-2451, 2023-09)Article de revueLibre accès -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
(PLoS Medicine. vol. 19, n° 1, 2022-01-11)Article de revueLibre accès -
Global Variations in Event-Based Surveillance for Disease Outbreak Detection: Time Series Analysis
(JMIR Public Health and Surveillance. vol. 8, n° 10, 2022-10-31)Article de revueLibre accès -
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)
(Trials. vol. 21, n° 1, pp. 846, 2020-10-13)Article de revueLibre accès